Egbert Floppercough and the Chronicles of Pharma: Tales Innovation, Illusion Patient Access to Medicines

Welcome to the pharmaceutical industry-where a breakthrough can survive years of clinical development and still be defeated by a spreadsheet, a reimbursement committee, a missing customs form, or a meeting scheduled to discuss another meeting.Egbert Floppercough is an industry everyman armed with optimism, PowerPoint, strong coffee and an impressive collection of increasingly mysterious job titles.Across 37 satirical chronicles, Egbert navigates the strange territory between scientific innovation and the moment a medicine actually reaches a patient.He encounters disappearing patients, questionable biomarkers, real-world evidence rabbit holes, artificial intelligence with too much confidence, compliance labyrinths, HTA huddles, elusive Key Opinion Leaders, impossible clinical trials, patent cliffs, safety signals, supply-chain disasters and the ethical dilemmas of compassionate use.And just when Egbert thinks he understands market access, Europe introduces Joint Clinical Assessment and the PICO Hydra appears-while Most-Favoured-Nation pricing turns every country's medicine price into everybody else's problem.Behind the absurdity lies a serious question: what does innovation mean if patients cannot access it?Funny, informed and occasionally uncomfortable, Egbert Floppercough and the Chronicles of Pharma explores the gap between the elegant strategy and healthcare as it actually works.For anyone working in pharmaceuticals, biotechnology, market access, HEOR, HTA, medical affairs, regulatory affairs, healthcare policy-or anyone who has ever attended a meeting that could have been an email.